The safety and efficacy of Celgene's CAR T cell therapies are under investigation and have not been established. There is no guarantee that these agents will receive health authority approval or become commercially available in any country for the uses being investigated.

Cancer Immune Response

Refresh your knowledge about the immune response to cancer, and how cancer can evade detection

CAR T Science

Learn about the science behind CAR T cell therapies

B Cell Malignancies

Learn about unmet needs in select B cell malignancies

CAR T Process

Learn what the CAR T therapy process may involve for you and your patients

Register to Learn More

Register today to start the conversation and let us know what types of information you are interested in.

All fields are required

Tell us about yourself

Preferred method of contact

Select one

Please indicate your areas of interest

Select all that apply


Select one

I am based

Select one

This information is intended for healthcare professionals. By completing and submitting this form, you certify that you are a licensed healthcare professional, and you are indicating that you would like to receive more information from Juno Therapeutics, a Celgene company.

By completing and submitting this form, you agree to allow Celgene to collect the information provided and to be contacted by Celgene in the future regarding related disease education and research updates.

Juno Therapeutics will not sell, rent, or otherwise distribute your information outside of Juno Therapeutics and related third parties. Juno Therapeutics will only use the information you enter in accordance with its Privacy Policy.

This website is intended for US healthcare professionals only. Are you a US healthcare professional?